Agenda - Workshop on the use of Bayesian statistics in clinical development
Submitted by Anonymous (not verified) on 12 June 2025 - 9:28
Agenda - Workshop on the use of Bayesian statistics in clinical development
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0117/2024
Submitted by Anonymous (not verified) on 11 June 2025 - 15:41
Opinion/decision on a Paediatric investigation plan (PIP): Olumiant, Baricitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0117/2024
EMEA-002362-PIP02-19-M03
Submitted by Anonymous (not verified) on 11 June 2025 - 15:34
EMEA-002362-PIP02-19-M03
EMEA-001823-PIP01-15-M03
Submitted by Anonymous (not verified) on 11 June 2025 - 15:30
EMEA-001823-PIP01-15-M03
PSUSA/00001989/202408
Submitted by Anonymous (not verified) on 11 June 2025 - 15:20
PSUSA/00001989/202408
PSUSA/00001455/202410
Submitted by Anonymous (not verified) on 11 June 2025 - 15:15
PSUSA/00001455/202410
EMEA-002780-PIP02-20-M01
Submitted by Anonymous (not verified) on 11 June 2025 - 15:10
EMEA-002780-PIP02-20-M01
PSUSA/00010386/202410
Submitted by Anonymous (not verified) on 11 June 2025 - 15:10
PSUSA/00010386/202410
EMEA-002486-PIP04-21-M01
Submitted by Anonymous (not verified) on 11 June 2025 - 15:04
EMEA-002486-PIP04-21-M01
EMEA-000813-PIP01-09-M01
Submitted by Anonymous (not verified) on 11 June 2025 - 14:39
EMEA-000813-PIP01-09-M01